[1]
B. J. Miles, “Referral and treatment rates of neoadjuvant chemotherapy in muscle-invasive bladder cancer before and after publication of a clinical practice guideline”, CUAJ, vol. 4, no. 4, pp. 263–7, Apr. 2013.